Bill Search

HR 1076
  • Introduced
    Feb 17, 2023
  • Passed House
  • Passed Senate
  • Signed into Law
    Sep 13, 2024
HR 1076
United States House Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Preventing the Financing of Illegal Synthetic Drugs Act
Last Action See all actions
Senate • Sep 13, 2024: Became Public Law No: 118-79.
Latest Bill Text See all bill texts
Enrolled Bill

Summary/Bill Text

Comments on HR 1076

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Sep 13, 2024 | Senate
    • Signed by President.
    • Became Public Law No: 118-79.
  • Sep 11, 2024 | Senate
    • Presented to President.
  • Jul 24, 2024 | Senate
    • Message on Senate action sent to the House.
  • Jul 23, 2024 | Senate
    • Senate Committee on Banking, Housing, and Urban Affairs discharged by Unanimous Consent.
    • Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
    • Passed Senate without amendment by Unanimous Consent. (consideration: CR S5319; text: CR S5319)
  • May 30, 2023 | Senate
    • Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
  • May 22, 2023 | House
    • Reported (Amended) by the Committee on Financial Services. H. Rept. 118-75, Part I.
    • Committee on the Judiciary discharged.
    • Committee on Energy and Commerce discharged.
    • Placed on the Union Calendar, Calendar No. 55.
    • Mr. Luetkemeyer moved to suspend the rules and pass the bill, as amended.
    • Considered under suspension of the rules. (consideration: CR H2469-2471)
    • DEBATE - The House proceeded with forty minutes of debate on H.R. 1076.
    • At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
    • Considered as unfinished business. (consideration: CR H2483)
    • Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 2 (Roll no. 228). (text: CR H2469)
    • On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 2 (Roll no. 228). (text: CR H2469)
    • Motion to reconsider laid on the table Agreed to without objection.
  • Feb 28, 2023 | House
    • Committee Consideration and Mark-up Session Held.
    • Ordered to be Reported in the Nature of a Substitute (Amended) by Voice Vote.
  • Feb 24, 2023 | House
    • Referred to the Subcommittee on Health.
  • Feb 17, 2023 | House
    • Introduced in House
    • Referred to the Committee on Financial Services, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bill Texts
Documents
Sources